NOUS-209
nouscom
['solid tumor', 'nouscom']
nouscom announces positive full phase 1 data of nous-209, an off-the-shelf neoantigen cancer immunotherapy for the treatment of dmmr/msi-h solid tumors, at asco 2022 #stocksmarket #pressrelease
Join us at https://t.co/9QZSYoqhvl - Stock Market News and Press Releases. #StockMarket - As an affiliate, we earn from qualifying purchases.